Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Entorhinal cortex layer II neurons (also known as stellate cells or grid cells) are the primary gateway for information flowing between the hippocampus and neocortex. These neurons are among the earliest and most severely affected in Alzheimer's disease, representing the first cortical region where neurofibrillary tangles appear. Their degeneration underlies the characteristic episodic memory deficits that mark AD onset.
The entorhinal cortex (EC) lies in the medial temporal lobe, forming the major interface between the hippocampus and neocortex. Layer II neurons are located in the superficial portion of the external pyramidal layer.
Cytoarchitecture:
- Layer I: Molecular layer (fibers)
- Layer II: Stellate cell layer (primary neurons)
- Layer III: External pyramidal layer
- Layer IV: Internal granular layer
- Layer V: Internal pyramidal layer
- Layer VI: Multiform layer
Layer II Stellate Cells:
- Primary input to dentate granule cells (perforant path)
- Grid cell properties
- Head direction inputs
- Spatial navigation
Layer II pyramidal neurons:
- Complementary input pathway
- Different firing patterns
- Reelin: Layer II specific marker
- WFS1: Wolfram syndrome 1 protein
- Calbindin: Calcium binding protein
- COUP-TFII: Nuclear receptor
- Primary: Glutamate (excitatory)
- Co-transmitters: Neuropeptide Y
- NMDA receptors: Synaptic plasticity
- AMPA receptors: Fast excitation
- Muscarinic ACh: Modulation
- Neocortical: Sensory, association areas
- Subcortical: Cholinergic (septal), serotonergic (raphe)
- Local: Other EC layers
- Perforant path: To dentate gyrus
- Mossy fibers: CA3 region
- Association fibers: To other hippocampal areas
Braak Stages:
- Stage I-II: EC layer II first affected
- Stage III-IV: Hippocampus proper
- Neocortex in later stages
Tau Pathology:
- Hyperphosphorylated tau
- NFTs in cell bodies and dendrites
- Pre-tangles in early stages
- Early: 30-60% loss in EC layer II
- Before clinical symptoms: Detectable
- Correlates with memory deficits: Strong correlation
- Plaques: Less correlated with dysfunction
- Initial deposition: Neocortex
- Later spread: EC involvement
- Hexagonal firing fields: Spatial representation
- Frequency reduction: Early in AD
- Implications: Navigation deficits
- Tau pathology: Direct effect on neurons
- Network disruption: Hippocampal circuit dysfunction
- Metabolic changes: Energy impairment
- Episodic memory: First and most severe
- Spatial memory: Navigation difficulties
- Prospective memory: Future planning
- CSF biomarkers: Tau, amyloid
- Structural MRI: EC atrophy
- FDG-PET: Hypometabolism
- FDDNP-PET: Tau binding
- EC thickness: Early marker
- CSF tau: Phosphorylated tau
- Neural activity: Functional changes
- Anti-tau antibodies: Immunotherapies
- Tau aggregation inhibitors: Small molecules
- mTOR inhibitors: Autophagy enhancement
- Cholinesterase inhibitors: Partial benefit
- Memory training: Compensatory strategies
- Cognitive stimulation
- Transgenic tau models: MAPT mutations
- APP/PS1 models: Amyloid models
- Combined models: Amyloid + tau
- iPSC-derived neurons: Patient-specific
- Brain organoids: Entorhinal-like regions
The study of Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Layer II entorhinal neurons are the first cortical neurons to develop neurofibrillary tangles (NFTs) in Alzheimer's disease:
- Braak Stage I: NFTs appear in the transentorhinal region
- Early memory impairment: Correlates with episodic memory deficits
- Tau pathology spread: Serves as staging ground for hippocampal spread
- EC layer II: Shows early amyloid plaque deposition
- Perforant path dysfunction: Synaptic loss in the dentate gyrus
- Network disruption: Impaired communication between entorhinal cortex and hippocampus
- Perforant path degradation: Primary input to dentate gyrus compromised
- Grid cell impairment: Spatial navigation deficits in early AD
- Memory encoding failure: Cannot form new episodic memories
- Excitotoxicity: Excessive glutamate leading to neuronal death
- Oxidative stress: Elevated ROS in entorhinal neurons
- Mitochondrial dysfunction: Energy deficit in highly active neurons
- Neuroinflammation: Microglial activation surrounding affected neurons
- Anti-tau therapies: Targeting tau aggregation and spread
- Anti-amyloid antibodies: Lecanemab, donanemab
- Neuroprotective agents: BDNF enhancement, antioxidants
- Acetylcholinesterase inhibitors: May preserve remaining function
- NMDA receptor modulators: Memantine for excitotoxicity
- Lifestyle interventions: Exercise, cognitive stimulation
- Early detection: CSF biomarkers for entorhinal atrophy
- Neuroimaging: PET tau ligands, structural MRI
- Regeneration studies: Stem cell approaches for layer II neurons
- Braak & Braak (1991) - Neurofibrillary changes in AD
- Kelley & Petersen (2007) - EC role in memory
- Strittmatter & Roses (1995) - Apolipoprotein E and AD
- Selkoe (2001) - Amyloid-beta hypothesis
- Ballatore et al. (2007) - Tau-mediated neurodegeneration